{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:15:24Z","timestamp":1765458924905,"version":"3.46.0"},"reference-count":32,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"2024 Shining Across China - Pharmaceutical Research Capacity Building Fund","award":["Z04J2023E095"],"award-info":[{"award-number":["Z04J2023E095"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Science OA"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/20565623.2025.2514969","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T08:04:21Z","timestamp":1750233861000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacoeconomic evaluation of carfilzomib\n                    <i>versus<\/i>\n                    ixazomib for the treatment of relapsed and refractory multiple myeloma"],"prefix":"10.1080","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4511-0008","authenticated-orcid":false,"given":"Lin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3057-4462","authenticated-orcid":false,"given":"Ruxu","family":"You","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00529-7"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.14.04033"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217440"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33326-3"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0625"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00431-5"},{"issue":"06","key":"e_1_3_6_8_1","first-page":"18","article-title":"\u4e2d\u56fd\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684\u76f4\u63a5\u533b\u7597\u8d39\u7528\u5206\u6790 [Analysis of direct medical costs for patients with multiple myeloma in China]","volume":"15","author":"Jin L","year":"2020","unstructured":"Jin L, Junfeng W, Li Y. \u4e2d\u56fd\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684\u76f4\u63a5\u533b\u7597\u8d39\u7528\u5206\u6790 [Analysis of direct medical costs for patients with multiple myeloma in China]. Chin J Drug Econ. 2020;15(06):18\u201323\u2009+\u200930. Chinese.","journal-title":"Chin J Drug Econ"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.5032"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.galenos.2021.2021.0052"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516282"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0501-4"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-03044-z"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00972"},{"key":"e_1_3_6_15_1","volume-title":"NICE DSU technical support document 19: partitioned survival analysis for decision modelling in health care: a critical review[R]","author":"Woods B","year":"2017","unstructured":"Woods B, Sideris E, Palmer S, et\u00a0al. NICE DSU technical support document 19: partitioned survival analysis for decision modelling in health care: a critical review[R]. York: NICE Decision Support Unit; 2017."},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1009920"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.608685"},{"issue":"08","key":"e_1_3_6_19_1","first-page":"11","article-title":"\u4f0a\u6c99\u4f50\u7c73\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u9aa8\u9ad3\u7624\u7684\u6210\u672c-\u6548\u7528\u5206\u6790 [Cost-utility analysis of ixazomib in the treatment of relapsed\/refractory myeloma]","volume":"16","author":"Bian Y","year":"2021","unstructured":"Bian Y, Wang R, Pan W, et\u00a0al. \u4f0a\u6c99\u4f50\u7c73\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u9aa8\u9ad3\u7624\u7684\u6210\u672c-\u6548\u7528\u5206\u6790 [Cost-utility analysis of ixazomib in the treatment of relapsed\/refractory myeloma]. China Pharmacoecon. 2021;16(08):11\u201316. Chinese","journal-title":"China Pharmacoecon"},{"issue":"06","key":"e_1_3_6_20_1","first-page":"590","article-title":"\u4e0d\u540c\u7ed9\u836f\u65b9\u6848\u6cbb\u7597\u533b\u9662\u83b7\u5f97\u6027\u80ba\u708e\u60a3\u8005\u7684\u7597\u6548\u548c\u6210\u672c\u5206\u6790\u53ca\u5bf9\u8840\u6e05 SPA \u6c34\u5e73\u7684\u5f71\u54cd [Efficacy and cost analysis of different dosing regimens for treating patients with hospital-acquired pneumonia and the effect on serum SPA levels]","volume":"24","author":"Zhao X","year":"2022","unstructured":"Zhao X, Wang X, Zhang P. \u4e0d\u540c\u7ed9\u836f\u65b9\u6848\u6cbb\u7597\u533b\u9662\u83b7\u5f97\u6027\u80ba\u708e\u60a3\u8005\u7684\u7597\u6548\u548c\u6210\u672c\u5206\u6790\u53ca\u5bf9\u8840\u6e05 SPA \u6c34\u5e73\u7684\u5f71\u54cd [Efficacy and cost analysis of different dosing regimens for treating patients with hospital-acquired pneumonia and the effect on serum SPA levels]. Southeastern Natl Defence Med. 2022;24(06):590\u2013595. Chinese.","journal-title":"Southeastern Natl Defence Med"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1005-376X.2002.01.019"},{"issue":"10","key":"e_1_3_6_22_1","first-page":"1344","article-title":"\u7ecf\u9888\u5916\u9759\u8109\u6cf5\u5165\u9ad8\u6d53\u5ea6\u94be\u62a2\u6551\u4f4e\u94be\u8840\u75c7 152 \u4f8b [Rescue of 152 cases of hypokalaemia by pumping high concentration of potassium through external jugular vein]","volume":"39","author":"Ma L LID.","year":"2010","unstructured":"Ma L LID. \u7ecf\u9888\u5916\u9759\u8109\u6cf5\u5165\u9ad8\u6d53\u5ea6\u94be\u62a2\u6551\u4f4e\u94be\u8840\u75c7 152 \u4f8b [Rescue of 152 cases of hypokalaemia by pumping high concentration of potassium through external jugular vein]. Shanxi Med J. 2010;39(10):1344\u20131346. Chinese.","journal-title":"Shanxi Med J"},{"issue":"16","key":"e_1_3_6_23_1","first-page":"2001","article-title":"\u5730\u585e\u7c73\u677e\u8054\u5408\u787c\u66ff\u4f50\u7c73\u4e0e\u6765\u90a3\u5ea6\u80fa\u6cbb\u7597\u65b0\u8bca\u65ad\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u6210\u672c-\u6548\u7528\u5206\u6790 [Cost-utility analysis of dexamethasone combined with bortezomib and lenalidomide for the treatment of newly diagnosed multiple myeloma]","volume":"33","author":"Huang D","year":"2022","unstructured":"Huang D, Zhu Y, Xiao Y, et\u00a0al. \u5730\u585e\u7c73\u677e\u8054\u5408\u787c\u66ff\u4f50\u7c73\u4e0e\u6765\u90a3\u5ea6\u80fa\u6cbb\u7597\u65b0\u8bca\u65ad\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u6210\u672c-\u6548\u7528\u5206\u6790 [Cost-utility analysis of dexamethasone combined with bortezomib and lenalidomide for the treatment of newly diagnosed multiple myeloma]. China Pharm. 2022;33(16):2001\u20132005\u2009+\u20092011. Chinese.","journal-title":"China Pharm"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.12.007"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.05.012"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.03.019"},{"issue":"09","key":"e_1_3_6_27_1","first-page":"1113","article-title":"\u66f2\u59a5\u73e0\u5355\u6297\u751f\u7269\u4eff\u5236\u836f\u5bf9\u6bd4\u539f\u7814\u836f\u6cbb\u7597\u590d\u53d1\u6216\u8f6c\u79fb\u6027 HER-2 \u9633\u6027\u4e73\u817a\u764c\u7684\u836f\u7269\u7ecf\u6d4e\u5b66\u8bc4\u4ef7 [Pharmacoeconomic evaluation of trastuzumab biosimilars versus the originator for the treatment of recurrent or metastatic HER-2-positive breast cancer]","author":"Xing Y","year":"2024","unstructured":"Xing Y, Liu T, Teng X, et\u00a0al. \u66f2\u59a5\u73e0\u5355\u6297\u751f\u7269\u4eff\u5236\u836f\u5bf9\u6bd4\u539f\u7814\u836f\u6cbb\u7597\u590d\u53d1\u6216\u8f6c\u79fb\u6027 HER-2 \u9633\u6027\u4e73\u817a\u764c\u7684\u836f\u7269\u7ecf\u6d4e\u5b66\u8bc4\u4ef7 [Pharmacoeconomic evaluation of trastuzumab biosimilars versus the originator for the treatment of recurrent or metastatic HER-2-positive breast cancer]. China Pharm. 2024;35(09):1113\u20131117. Chinese.","journal-title":"China Pharm"},{"key":"e_1_3_6_28_1","unstructured":"Shanghai Medical Insurance. [Internet]. Summary table of medical service prices in Shanghai (version 2024). 2023. [cited 2023 Dec 01]. Available from: https:\/\/ybj.sh.gov.cn\/qtwj\/"},{"issue":"11","key":"e_1_3_6_29_1","first-page":"12","article-title":"Pharmacoeconomic evaluation of liposomal amphotericin B for empirical treatment of invasive fungal infections]","volume":"21","author":"Zhu X","year":"2023","unstructured":"Zhu X, Wang C, Zheng Y, et\u00a0al. \u4e24\u6027\u9709\u7d20B\u8102\u8d28\u4f53\u7ecf\u9a8c\u6027\u6cbb\u7597\u4fb5\u88ad\u6027\u771f\u83cc\u611f\u67d3\u7684\u836f\u7269\u7ecf\u6d4e\u5b66\u8bc4\u4ef7[Pharmacoeconomic evaluation of liposomal amphotericin B for empirical treatment of invasive fungal infections]. J Clin Pharmacother. 2023;21(11):12\u201319. Chinese.","journal-title":"J Clin Pharmacother"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.24.1.29"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.24.1.39"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-019-01122-6"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0644-3"}],"container-title":["Future Science OA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20565623.2025.2514969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:07:45Z","timestamp":1765458465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20565623.2025.2514969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/20565623.2025.2514969"],"URL":"https:\/\/doi.org\/10.1080\/20565623.2025.2514969","relation":{},"ISSN":["2056-5623"],"issn-type":[{"type":"electronic","value":"2056-5623"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifso20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifso20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-01-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2514969"}}